Clinical Data Needed For Some Digital Mammography 510(k)s, Panel Says
This article was originally published in The Gray Sheet
Executive Summary
FDA should require some clinical data in 510(k) or de novo 510(k) submissions for new full-field digital mammography devices that substantially change or improve the perception of breast cancer images when compared with prior models, an FDA advisory panel recommended Nov. 17